![Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012 Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012](https://cdnsciencepub.com/cms/10.1139/cjm-2013-0614/asset/images/large/cjm-2013-0614f3.jpeg)
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
![Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press](https://nap.nationalacademies.org/books/0309038294/gifmid/392.gif)
Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press
![Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012 Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012](https://cdnsciencepub.com/cms/10.1139/cjm-2013-0614/asset/images/cjm-2013-0614tab2.gif)
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
![Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press](https://nap.nationalacademies.org/books/0309038294/gifmid/385.gif)
Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press
![PDF) Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study PDF) Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study](https://i1.rgstatic.net/publication/347304885_Safety_and_feasibility_of_umbilical_cord_mesenchymal_stem_cells_in_patients_with_COVID-19_pneumonia_A_pilot_study/links/60190850a6fdcc071bac4ce3/largepreview.png)
PDF) Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study
![Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press](https://nap.nationalacademies.org/books/0309038294/gifmid/361.gif)
Part 2: Assessment Report Citations Listed by Technology | Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources | The National Academies Press
![PDF) Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications PDF) Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications](https://www.researchgate.net/profile/Chen-Lijun/publication/358740391/figure/fig1/AS:11431281091627596@1666576143530/Basic-characteristics-and-entry-of-SARS-CoV-2-into-the-host-pneumocyte-a-Bats-and_Q320.jpg)